Related Experiment Video
Updated: Apr 17, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
[Relationship between kidney-related brain dysfunction and neuropathological changes in Parkinson's disease]
F A Yusupov1, M Sh Abdykadyrov1
1Osh State University, Osh, Kyrgyz Republic.
Biomarkers of renal dysfunction, like estimated glomerular filtration rate (eGFR) and cystatin C, may predict Parkinson's disease progression, particularly cognitive decline. The kidney-brain axis offers insights into neurodegeneration and potential therapeutic targets.
Area of Science:
- Nephrology
- Neurology
- Neuroscience
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder.
- The role of renal function in PD pathogenesis is increasingly recognized.
- Understanding the kidney-brain axis is crucial for PD management.
Purpose of the Study:
- To evaluate renal dysfunction biomarkers as prognostic indicators for PD progression.
- To explore pathophysiological links between renal and brain dysfunction in PD.
- To assess the predictive value of renal markers for motor and non-motor PD symptoms.
Main Methods:
- Systematic review of research papers published since 2020.
- Inclusion of studies from major scientific databases (Scopus, PubMed, Google Scholar, eLibrary).
Main Results:
- Decreased renal function (eGFR, cystatin C) correlates with cognitive impairment and PD severity.
- Uremic toxins, inflammation, and oxidative stress mediate alpha-synuclein neurodegeneration.
- Kidneys play a role in alpha-synuclein clearance; renal failure may exacerbate its accumulation.
Conclusions:
- Renal dysfunction biomarkers (eGFR, cystatin C) show prognostic potential for PD, especially cognitive decline.
- The kidney-brain axis, involving uremic toxins, inflammation, oxidative stress, and alpha-synuclein, is a key area for research.
- Further investigation may lead to novel therapeutic strategies for PD.
More Related Videos
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
11:53Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System
Published on: October 26, 2010
Related Concept Videos
Parkinson's Disease: Overview
Neural Regulation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Drug Toxicity: Dose-Dependent Reactions